Experimental studies have shown that diabetic patients release pro-inflammatory cytokines such as IL-1β, IL-6, and TNF-α, which may lead to neuronal death and accelerate neurodegenerative changes in Alzheimer’s disease (AD) (Puig et al., 2012). Here, IL6 is linked to early-onset autosomal dominant Alzheimer disease.